Siemens' syngo TrueD is designed for oncology, supporting PET/CT, SPECT/CT as well as CT or MR fused with PET or SPECT. The syngo TrueD was de-signed to allow physicians to compare patient scans from different time points (such as pre- and post-therapy) and provide advanced image analysis and comparison.
May 2008
April 20, 2026 — Bracco Imaging has announced a strategic alliance with NYU Langone Health to advance innovation in ...
April 23, 2026 
April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...
April 20, 2026 
April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...
April 09, 2026 
The Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 2026 Annual Meeting will take place May 30–June 2 in Los ...
April 07, 2026 
March 25, 2026 — Catalyst MedTech, a provider of nuclear medicine and molecular imaging solutions, has announced it is ...
April 06, 2026 
March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...
March 31, 2026 
March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...
March 30, 2026 
March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...
March 30, 2026 
March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...
March 25, 2026 
March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...
March 23, 2026 